About the company
BioAgilytix and 360biolabs deliver a unified global bioanalytical strategy, combining the speed and clinical advantages of early-phase development in Australia with integrated PK, immunogenicity, biomarker, and GMP testing services across Europe and the United States. Under harmonized quality systems and shared scientific leadership, we support programs from first-in-human through global late-phase studies.
Global Bioanalysis for Every Phase, Every Modality.